EU Medicines Regulation Achievements: EMA’...

By HEOR Staff Writer

March 16, 2026

The European Medicines Agency (EMA) Management Board highlights at its March 2026 meeting a robust year, with the adoption of the 2025 annual report...
Exploring MFN Policy Effectiveness in Drug Pricing and Innovation
Strategic Vision and Infarmed 2026 Priorities for Regulatory Reform
South Africa Health Reform: Navigating Innovations and Challenges for 2026
Launch of TrumpRx Drug Pricing: Savings on Essential Medications
Healthcare Innovation Trends Shaping the Future: Insights from the J.P. Morga...
Navigating Economic Resilience Through Life Sciences Investment
Guiding Principles for Ethical AI Integration in Drug Development
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
Driving Economic Transformation through Brain Health Investment in Africa
Novartis Drug Pricing Agreement
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...